- Investing Ideas
- Global Pharmaceuticals & Biotech Too Big To Fail
Global Pharmaceuticals & Biotech Too Big To Fail
Results
11
Large established companies which pay a dividend.
11 companies
Sanofi
Market Cap: €92.8b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SAN
€76.91
7D
-0.2%
1Y
-6.5%
Astellas Pharma
Market Cap: JP¥3.9t
Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.
4503
JP¥2,151.00
7D
0.4%
1Y
48.5%
Shionogi
Market Cap: JP¥2.4t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.
4507
JP¥2,876.00
7D
1.5%
1Y
15.4%
Orion Oyj
Market Cap: €10.9b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€75.20
7D
9.0%
1Y
8.5%
Krka d. d
Market Cap: €8.1b
A generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.
KRKG
€268.00
7D
1.1%
1Y
34.7%
Kyowa Kirin
Market Cap: JP¥1.4t
Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.
4151
JP¥2,654.50
7D
0.5%
1Y
5.2%
Ono Pharmaceutical
Market Cap: JP¥1.1t
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
4528
JP¥2,425.50
7D
-0.1%
1Y
51.6%
China Resources Sanjiu Medical & Pharmaceutical
Market Cap: CN¥42.5b
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
000999
CN¥25.55
7D
4.3%
1Y
-18.9%
Santen Pharmaceutical
Market Cap: JP¥657.0b
Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.
4536
JP¥2,042.50
7D
-4.3%
1Y
21.7%
Livzon Pharmaceutical Group
Market Cap: CN¥25.3b
Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People’s Republic of China and internationally.
000513
CN¥31.20
7D
2.3%
1Y
-23.5%
Apeloa PharmaceuticalLtd
Market Cap: CN¥22.5b
Provides raw materials various pharmaceutical factories in the People’s Republic of China and internationally.
000739
CN¥20.02
7D
10.1%
1Y
31.9%